Predictive Oncology Inc.
POAI
$1.06
-$0.03-2.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.57M | -10.88M | -10.88M | -11.62M | -10.82M |
| Total Depreciation and Amortization | 900.40K | 844.70K | 844.70K | 860.60K | 935.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.10K | 338.70K | 338.70K | 448.90K | 469.50K |
| Change in Net Operating Assets | -218.40K | -24.40K | -24.40K | 235.30K | -669.40K |
| Cash from Operations | -8.78M | -9.72M | -12.82M | -13.18M | -13.19M |
| Capital Expenditure | -9.50K | 6.00K | 6.00K | -242.90K | -264.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -8.20K | -8.20K | -11.90K | -34.20K |
| Cash from Investing | -9.50K | -2.20K | -6.10K | -258.70K | -302.30K |
| Total Debt Issued | 275.10K | 275.10K | 275.10K | 0.00 | 0.00 |
| Total Debt Repaid | -346.20K | -260.20K | -260.20K | -222.20K | -109.80K |
| Issuance of Common Stock | 3.70M | 3.70M | 3.70M | -- | -- |
| Repurchase of Common Stock | -- | -1.50K | -1.50K | -1.50K | -1.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -573.80K | -573.80K | -573.80K | -- | -- |
| Cash from Financing | 3.05M | 3.14M | 3.40M | 36.50K | 148.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.74M | -6.58M | -9.43M | -13.40M | -13.34M |